Is TransMedics Stock a Good Investment?
TransMedics Investment Advice | TMDX |
- Examine TransMedics' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research TransMedics' leadership team and their track record. Good management can help TransMedics navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact TransMedics' business and its evolving consumer preferences.
- Compare TransMedics' performance and market position to its competitors. Analyze how TransMedics is positioned in terms of product offerings, innovation, and market share.
- Check if TransMedics pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about TransMedics' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in TransMedics Group stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if TransMedics Group is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine TransMedics Stock
Researching TransMedics' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 97.0% of the company shares are owned by institutional investors. The company had not issued any dividends in recent years.
To determine if TransMedics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding TransMedics' research are outlined below:
| TransMedics Group generated a negative expected return over the last 90 days | |
| TransMedics Group has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 241.62 M. Net Loss for the year was (25.03 M) with profit before overhead, payroll, taxes, and interest of 65.27 M. | |
| TransMedics Group currently holds about 204.46 M in cash with (13.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.41. | |
| TransMedics Group has a frail financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: TransMedics Group Inc Shares Gap Down to 74.74 on Nov 22 |
TransMedics Quarterly Liabilities And Stockholders Equity |
|
TransMedics uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in TransMedics Group. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to TransMedics' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of February 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact TransMedics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises TransMedics' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-03-02 | 2019-12-31 | -0.39 | -0.43 | -0.04 | 10 | ||
2022-08-01 | 2022-06-30 | -0.35 | -0.41 | -0.06 | 17 | ||
2020-08-05 | 2020-06-30 | -0.42 | -0.36 | 0.06 | 14 | ||
2019-11-06 | 2019-09-30 | -0.45 | -0.39 | 0.06 | 13 | ||
2023-02-22 | 2022-12-31 | -0.3 | -0.21 | 0.09 | 30 | ||
2023-08-03 | 2023-06-30 | -0.13 | -0.03 | 0.1 | 76 | ||
2021-11-09 | 2021-09-30 | -0.36 | -0.47 | -0.11 | 30 | ||
2021-08-05 | 2021-06-30 | -0.28 | -0.39 | -0.11 | 39 |
Know TransMedics' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as TransMedics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading TransMedics Group backward and forwards among themselves. TransMedics' institutional investor refers to the entity that pools money to purchase TransMedics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Eventide Asset Management, Llc | 2024-09-30 | 690.6 K | Allspring Global Investments Holdings, Llc | 2024-06-30 | 569 K | Mackenzie Investments | 2024-09-30 | 478.7 K | Fuller & Thaler Asset Management Inc | 2024-09-30 | 456.5 K | 1832 Asset Management L.p | 2024-09-30 | 455.4 K | Bank Of New York Mellon Corp | 2024-06-30 | 420.7 K | Sandhill Capital Partners Llc | 2024-09-30 | 392.6 K | Fidelity International Ltd | 2024-06-30 | 376.8 K | Man Group Plc | 2024-09-30 | 345.3 K | Vanguard Group Inc | 2024-09-30 | 3.6 M | Blackrock Inc | 2024-06-30 | 2.6 M |
TransMedics' market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.55 B.Market Cap |
|
TransMedics' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.04) | (0.04) | |
| Return On Capital Employed | (0.04) | (0.05) | |
| Return On Assets | (0.04) | (0.04) | |
| Return On Equity | (0.18) | (0.17) |
Determining TransMedics' profitability involves analyzing its financial statements and using various financial metrics to determine if TransMedics is a good buy. For example, gross profit margin measures TransMedics' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of TransMedics' profitability and make more informed investment decisions.
TransMedics' Earnings Breakdown by Geography
Please note, the imprecision that can be found in TransMedics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of TransMedics Group. Check TransMedics' Beneish M Score to see the likelihood of TransMedics' management manipulating its earnings.
Evaluate TransMedics' management efficiency
TransMedics Group has return on total asset (ROA) of 0.0284 % which means that it generated a profit of $0.0284 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1941 %, meaning that it created $0.1941 on every $100 dollars invested by stockholders. TransMedics' management efficiency ratios could be used to measure how well TransMedics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.04 in 2024. Return On Capital Employed is likely to drop to -0.05 in 2024. At this time, TransMedics' Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 226.3 M in 2024, whereas Intangible Assets are likely to drop slightly above 1.9 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.22 | 4.43 | |
| Tangible Book Value Per Share | 3.78 | 3.97 | |
| Enterprise Value Over EBITDA | (353.51) | (335.83) | |
| Price Book Value Ratio | 18.71 | 19.64 | |
| Enterprise Value Multiple | (353.51) | (335.83) | |
| Price Fair Value | 18.71 | 19.64 | |
| Enterprise Value | 2.7 B | 2.8 B |
Management at TransMedics Group focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Beta 2.071 |
Basic technical analysis of TransMedics Stock
As of the 25th of November, TransMedics has the Coefficient Of Variation of (455.21), variance of 25.1, and Risk Adjusted Performance of (0.16). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of TransMedics Group, as well as the relationship between them.TransMedics' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific TransMedics insiders, such as employees or executives, is commonly permitted as long as it does not rely on TransMedics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases TransMedics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
TransMedics' Outstanding Corporate Bonds
TransMedics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. TransMedics Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most TransMedics bonds can be classified according to their maturity, which is the date when TransMedics Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand TransMedics' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing TransMedics' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.16) | |||
| Market Risk Adjusted Performance | (0.56) | |||
| Mean Deviation | 3.1 | |||
| Coefficient Of Variation | (455.21) | |||
| Standard Deviation | 5.01 | |||
| Variance | 25.1 | |||
| Information Ratio | (0.25) | |||
| Jensen Alpha | (1.35) | |||
| Total Risk Alpha | (1.90) | |||
| Treynor Ratio | (0.57) | |||
| Maximum Drawdown | 39.98 | |||
| Value At Risk | (7.44) | |||
| Potential Upside | 4.04 | |||
| Skewness | (2.82) | |||
| Kurtosis | 16.22 |
| Risk Adjusted Performance | (0.16) | |||
| Market Risk Adjusted Performance | (0.56) | |||
| Mean Deviation | 3.1 | |||
| Coefficient Of Variation | (455.21) | |||
| Standard Deviation | 5.01 | |||
| Variance | 25.1 | |||
| Information Ratio | (0.25) | |||
| Jensen Alpha | (1.35) | |||
| Total Risk Alpha | (1.90) | |||
| Treynor Ratio | (0.57) | |||
| Maximum Drawdown | 39.98 | |||
| Value At Risk | (7.44) | |||
| Potential Upside | 4.04 | |||
| Skewness | (2.82) | |||
| Kurtosis | 16.22 |
Consider TransMedics' intraday indicators
TransMedics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of TransMedics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
TransMedics Corporate Filings
F4 | 13th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 29th of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 28th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 7th of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
TransMedics Stock media impact
Far too much social signal, news, headlines, and media speculation about TransMedics that are available to investors today. That information is available publicly through TransMedics media outlets and privately through word of mouth or via TransMedics internal channels. However, regardless of the origin, that massive amount of TransMedics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of TransMedics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of TransMedics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to TransMedics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive TransMedics alpha.
TransMedics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards TransMedics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
TransMedics Group Historical Investor Sentiment
Investor biases related to TransMedics' public news can be used to forecast risks associated with an investment in TransMedics. The trend in average sentiment can be used to explain how an investor holding TransMedics can time the market purely based on public headlines and social activities around TransMedics Group. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
TransMedics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for TransMedics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average TransMedics news discussions. The higher the estimate score, the more favorable the investor's outlook on TransMedics.
TransMedics Corporate Management
| Miriam Provost | Vice Affairs | Profile | |
| Mark Anderson | Senior Development | Profile | |
| Susan Goodman | Vice Resources | Profile | |
| John Carey | VP Operations | Profile | |
| Nick Corcoran | Senior Operations | Profile | |
| Tamer MD | Chief Officer | Profile |
Additional Tools for TransMedics Stock Analysis
When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.